ATE17738T1 - Mitogene aus leukozyten und entzuendeten geweben: natuerliche leukopoietische proteine fuer die spezifische induktion der vermehrung und der differenzierung von leukozyten; verfahren zu ihrer biotechnischen herstellung und pharmazeutische zusammensetzungen. - Google Patents

Mitogene aus leukozyten und entzuendeten geweben: natuerliche leukopoietische proteine fuer die spezifische induktion der vermehrung und der differenzierung von leukozyten; verfahren zu ihrer biotechnischen herstellung und pharmazeutische zusammensetzungen.

Info

Publication number
ATE17738T1
ATE17738T1 AT82102160T AT82102160T ATE17738T1 AT E17738 T1 ATE17738 T1 AT E17738T1 AT 82102160 T AT82102160 T AT 82102160T AT 82102160 T AT82102160 T AT 82102160T AT E17738 T1 ATE17738 T1 AT E17738T1
Authority
AT
Austria
Prior art keywords
leukocytes
differentiation
pharmaceutical compositions
leukopoietic
mitogene
Prior art date
Application number
AT82102160T
Other languages
English (en)
Inventor
Josef H Dr Wissler
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE17738T1 publication Critical patent/ATE17738T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
AT82102160T 1981-03-18 1982-03-17 Mitogene aus leukozyten und entzuendeten geweben: natuerliche leukopoietische proteine fuer die spezifische induktion der vermehrung und der differenzierung von leukozyten; verfahren zu ihrer biotechnischen herstellung und pharmazeutische zusammensetzungen. ATE17738T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813110611 DE3110611A1 (de) 1981-03-18 1981-03-18 "mitogene der leukozyten und des entzuendungsgewebes:natuerliche leukopoetine zur selektiven anregung der teilung und differenzierung von leukozyten"
EP82102160A EP0061139B1 (de) 1981-03-18 1982-03-17 Mitogene aus Leukozyten und entzündeten Geweben: natürliche leukopoietische Proteine für die spezifische Induktion der Vermehrung und der Differenzierung von Leukozyten; Verfahren zu ihrer biotechnischen Herstellung und pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE17738T1 true ATE17738T1 (de) 1986-02-15

Family

ID=6127665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82102160T ATE17738T1 (de) 1981-03-18 1982-03-17 Mitogene aus leukozyten und entzuendeten geweben: natuerliche leukopoietische proteine fuer die spezifische induktion der vermehrung und der differenzierung von leukozyten; verfahren zu ihrer biotechnischen herstellung und pharmazeutische zusammensetzungen.

Country Status (8)

Country Link
US (1) US4512971A (de)
EP (1) EP0061139B1 (de)
JP (1) JPS5849319A (de)
AT (1) ATE17738T1 (de)
AU (1) AU550390B2 (de)
CA (1) CA1188242A (de)
DE (2) DE3110611A1 (de)
DK (1) DK118882A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720482A (en) * 1982-10-20 1988-01-19 Dana Farber Cancer Institute Pharmaceutical compositions containing one or more lymphocyte growth factors
JPS6178483A (ja) * 1984-09-25 1986-04-22 Mitsui Eng & Shipbuild Co Ltd 焼却灰の固化方法
JPS61174984A (ja) * 1985-01-30 1986-08-06 Denki Kagaku Kogyo Kk 焼却灰の固化方法
US5484885A (en) * 1989-07-05 1996-01-16 Emory University Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
IL96477A0 (en) * 1989-12-01 1991-08-16 Amgen Inc Megakaryocyte production
US5328989A (en) * 1993-03-05 1994-07-12 Schering-Plough Purification of human interleukin-10 from a cell culture medium
US5650060A (en) * 1994-01-28 1997-07-22 Minnesota Mining And Manufacturing Company Ionically conductive agent, system for cathodic protection of galvanically active metals, and method and apparatus for using same
MXPA03008096A (es) * 2001-03-08 2005-10-05 Univ Kentucky Res Found Metodo para aumentar los niveles de leptina utilizando compuestos de acido nicotinico.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342828A (en) * 1979-07-20 1982-08-03 Morinaga Milk Industry Co., Ltd. Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells

Also Published As

Publication number Publication date
EP0061139A3 (en) 1983-06-01
DE3268743D1 (en) 1986-03-13
AU8163582A (en) 1982-09-23
US4512971A (en) 1985-04-23
DE3110611A1 (de) 1982-10-07
CA1188242A (en) 1985-06-04
JPS5849319A (ja) 1983-03-23
AU550390B2 (en) 1986-03-20
EP0061139B1 (de) 1986-01-29
DK118882A (da) 1982-09-19
EP0061139A2 (de) 1982-09-29

Similar Documents

Publication Publication Date Title
AU550434B2 (en) Angiotropins of leukocytes and inflamed tissues
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
MA26555A1 (fr) Composes inhibant la map kinase p38, compositions pharmaceutiques les contenant, leur utilisation, procede pour la preparation de ces composes et produits intermediaires utiles dans ce procede.
AU2885295A (en) Novel hIL-4 mutant proteins as antagonists or partial agonists of human interleukin 4
DE3271862D1 (en) Chemokinesins and chemotaxins of leukocytes and inflamed tissues: natural mediator proteins for reversible promotion of random and directional locomotion (chemokinesis and chemotaxis) for accumulation of specific leukocyte types, process of their biotechnical preparation and pharmaceutical compositions
ATE17738T1 (de) Mitogene aus leukozyten und entzuendeten geweben: natuerliche leukopoietische proteine fuer die spezifische induktion der vermehrung und der differenzierung von leukozyten; verfahren zu ihrer biotechnischen herstellung und pharmazeutische zusammensetzungen.
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
IL81221A0 (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them
PT86635A (pt) Process for the preparation of novel 4-aryl-n-]2-(dialkylamino and heterocyclicamino)-alkyl"-1-piperazinecarboxamides and of pharmaceutical compositions containing the same
ATE87916T1 (de) 3-desmethyl-4-fluor-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung und zwischenprodukte.
EP0249247A3 (de) Purinderivate
KR970706838A (ko) 조혈 단백질을 사용한 적혈구생성을 자극하는 방법(methods for stimulating erythropoiesis using hematopoietic proteins)
EP0298350A3 (de) Chirale 6-Hydroxymethylenverzweigte 3-Amino-4,5-dihydroxypiperidine, Zwischenprodukte zu ihrer Herstellung, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE44950T1 (de) Polyprenylverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
TNSN97033A1 (fr) Nouvelles heteroaryl-oxazolidinones, procede pour les preparer, et leur utilisation en tant que medicaments.
DE3268622D1 (en) Chemorecruitins of leukocytes and inflamed tissues: a new class of natural leukopoietin proteins for chemorecruitment of specific leukocyte types from the bone marrow into blood circulation (leukocytosis and leftward shift reactions), process for their biotechnical preparation and pharmaceutical compositions
ATE163424T1 (de) Neue 17-(3-imino-2-alkyl-propenyl)-5beta-14beta- androstanderivate, zur behandlung von kardiovaskulären erkrankungen, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
Fuhr et al. Evaluation of commercial erythropoietin activity after preparative isoelectric focusing
ATE66468T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten.
JPS61126031A (ja) コロニ−形成刺激因子の製造法
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
DE59704883D1 (de) Komplex aus antigen und zellbestandteil, verfahren zur dessen herstellung und therapeutische verwendungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee